Tue Sep 10 00:06:59 UTC 2024: ## Twist Bioscience Sees Increased Investor Interest Amidst Insider Sales

**San Francisco, CA -** Twist Bioscience Co. (NASDAQ: TWST) has attracted significant investor interest in recent months, with several large investors increasing their holdings in the company’s stock. This comes amidst insider sales that have raised eyebrows.

Strategic Financial Concepts LLC, Los Angeles Capital Management LLC, Arizona State Retirement System, Victory Capital Management Inc., Privium Fund Management B.V., and Principal Financial Group Inc. all made notable purchases of Twist Bioscience shares during the second quarter. This indicates a positive outlook on the company’s future prospects.

However, insider trading activity has also been noteworthy. Dennis Cho and Paula Green, both senior executives at Twist Bioscience, sold shares of the company in August. While the total value of these sales was relatively small, the timing of these transactions has sparked questions about the company’s internal outlook.

Overall, Twist Bioscience’s stock performance has been mixed. The company’s recent earnings report showed a miss on analyst estimates, with a negative net margin and return on equity. However, revenue growth was significant, indicating potential for future profitability.

Despite the recent insider sales, the significant investment activity by large institutional investors suggests that the company’s long-term prospects remain positive. The synthetic DNA market is expected to grow significantly in the coming years, and Twist Bioscience is well-positioned to capitalize on this trend.

**Disclaimer:** This news article is based on publicly available information and should not be construed as financial advice.

Read More